The DEEP project has received research funding from the European Union under the 7th Framework Programme

recruitment

DEEP-2: almost at the final rush

marzo 25, 2016
|
Comments off
|

Another step forward has been made toward the enrollment of new patients in the DEEP-2 study, the phase III multicentre, randomised, open label, non-inferiority active-controlled trial aiming at comparing for the first time the efficacy of deferiprone (DFP) vs deferasirox (DFX) in paediatric patients affected […]

Share
Read more →